Means and standard deviations of plasma TMAO in the supplemented and placebo groups, before and after three months of LC treatment, were applied with the alpha level and the power of the test set at 0.05 and 0.95, respectively
Insulin regulates brain function, but how does it get there
Regenerative and protective actions of GHK-Cu peptide
Giugliano D, Longo M, Scappaticcio L, et al
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)